IndraLab

Statements

P5091 activates sensitivity bortezomib-resistant cancer cells. 1 / 1

| 1

eidos

"P5091 restores sensitivity to bortezomib-resistant cancer cells , and shows synergistic effects when combined with proteasome and histone deacetylase ( HDAC ) inhibitors [ 108 ] ."

| PMC

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 activates sensitivity bortezomib-resistant cancer cells. 1 / 1

INDRA sources:

Databases

Reading